In fact, large-scale clinical trials for branded medications like Ozempic and Wegovy have shown that they may actually reduce the risk of major cardiovascular events, such as heart attacks and strokes, in high-risk patients
Ozempic is also commonly used off-label for weight loss
Apolipoprotein e and alzheimers disease: the influence of apolipoprotein e on amyloid-beta and other amyloidogenic proteins
The drugs work by mimicking the action of a natural hormone called GLP-1, which helps regulate blood sugar levels
Primary endpoints included adverse events, SARS-CoV-2 infection incidence in Cohort 1, and disease progressions in Cohort 2
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed for type 2 diabetes, administered weekly by subcutaneous injection